Ronald K. Scheule
18Patents
11h-index
41Co-inventors
72Inventor score
Filing activity: Oct 11, 1995 → Apr 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5948767A | Cationic amphiphile/DNA complexes | Chemistry; Metallurgy | 146 | Expired |
| US5719131A | Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules | Emerging Cross-Sectional Technologies | 69 | Expired |
| US5935936A | Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules | Chemistry; Metallurgy | 55 | Expired |
| US5783565A | Cationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic molecules | Emerging Cross-Sectional Technologies | 49 | Expired |
| US6071890A | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy | Chemistry; Metallurgy | 37 | Expired |
| US5840710A | Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules | Emerging Cross-Sectional Technologies | 32 | Expired |
| US8003617B2 | Methods of treating diabetes mellitus | Human Necessities | 20 | Active |
| US5747471A | Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules | Chemistry; Metallurgy | 19 | Expired |
| US6383814B1 | Cationic amphiphiles for intracellular delivery of therapeutic molecules | Chemistry; Metallurgy | 18 | Expired |
| US5939401A | Cationic amphiphile compositions for intracellular delivery of therapeutic molecules | Human Necessities | 17 | Expired |
| US5910487A | Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules | Chemistry; Metallurgy | 15 | Expired |
| US11008316B2 | Glucosylceramide synthase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9532976B2 | Method of lowering blood glucose | Human Necessities | 4 | Active |
| US6465007B1 | Transgene expression in polarized cells | Human Necessities | 2 | Expired |
| US6331524A | Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy | Chemistry; Metallurgy | 1 | Expired |
| US11801311B2 | Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotides | Chemistry; Metallurgy | 0 | Active |
| US12060349B2 | Glucosylceramide synthase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10682423B2 | Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.